rheumatology
Bone health

Bisphosphonate holidays raise risk of hip fracture in osteoporotic women

Women who discontinue bisphosphonates for more than two years have up to a 40% greater risk of hip fracture, a US study presented at EULAR 2018 here in Amsterdam has shown. Taking bisphosphonate therapy for three to four years is known to reduce fracture risk in osteoporotic women, but the question of how long to ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic